The Latest in Psoriasis

Alopecia may be permanent in one in four pediatric HSCT patients

August 2, 2017

Psoriasis

Adalimumab for Hidradenitis Suppurativa

August 2, 2017

Psoriasis

First interchangeability study for an adalimumab biosimilar has begun

July 31, 2017

Psoriasis

Unresolved fatigue lingers for most PsA patients

July 17, 2017

Psoriasis

Children with psoriasis face multitude of comorbidities

July 15, 2017

Psoriasis

Ixekizumab helps PsA patients who failed a TNFi

July 14, 2017

Psoriasis

First IL-23 blocker, guselkumab, earns FDA approval for psoriasis

July 13, 2017

Psoriasis

Comorbidities in psoriatic arthritis flag worse prognosis

July 8, 2017

Psoriasis

FDA approves abatacept for adults with psoriatic arthritis

July 7, 2017

Psoriasis

Phototherapy Coding and Documentation in the Time of Biologics

July 5, 2017

Psoriasis

Topical Cannabinoids in Dermatology

July 5, 2017

Psoriasis

Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsA

July 1, 2017

Psoriasis

TWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitis

June 28, 2017

Psoriasis

Pain often persists despite biologic treatment in PsA

June 16, 2017

Psoriasis

Phototherapy and Nondrug Therapies for Psoriasis Considered Beneficial by Patients

June 12, 2017

Psoriasis